Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
62.97
+3.13 (5.23%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Rhythm Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 89.14 | 60.08 | 127.68 | 59.25 | 100.85 | Upgrade
|
| Short-Term Investments | 231.43 | 215.77 | 205.61 | 235.61 | 71.94 | Upgrade
|
| Cash & Short-Term Investments | 320.57 | 275.85 | 333.29 | 294.86 | 172.79 | Upgrade
|
| Cash Growth | 16.21% | -17.23% | 13.04% | 70.64% | -40.92% | Upgrade
|
| Receivables | 18.51 | 14.87 | 6.22 | 1.03 | - | Upgrade
|
| Inventory | 18.74 | 8.62 | 2.92 | 0.11 | - | Upgrade
|
| Other Current Assets | 16.38 | 8.93 | 11.81 | 12.4 | 8.88 | Upgrade
|
| Total Current Assets | 374.2 | 308.27 | 354.24 | 308.39 | 181.67 | Upgrade
|
| Property, Plant & Equipment | 4.11 | 2.12 | 3.38 | 4.34 | 5 | Upgrade
|
| Other Intangible Assets | 6.17 | 7.03 | 7.88 | 4.66 | - | Upgrade
|
| Long-Term Deferred Charges | 6.21 | 12.59 | - | - | - | Upgrade
|
| Other Long-Term Assets | 1.58 | 2.73 | 16.98 | 12.14 | 0.4 | Upgrade
|
| Total Assets | 392.27 | 332.75 | 382.48 | 329.52 | 187.07 | Upgrade
|
| Accounts Payable | 12.33 | 4.89 | 4.8 | 5.74 | 4.9 | Upgrade
|
| Accrued Expenses | 58.31 | 42.85 | 30.48 | 29.26 | 12.56 | Upgrade
|
| Current Portion of Long-Term Debt | 1.54 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.77 | 0.68 | 0.61 | 0.54 | Upgrade
|
| Current Unearned Revenue | 1.29 | 1.29 | 1.43 | 7 | - | Upgrade
|
| Other Current Liabilities | 42.05 | 5.41 | 2.42 | 0.83 | - | Upgrade
|
| Total Current Liabilities | 115.52 | 55.2 | 39.81 | 43.43 | 17.99 | Upgrade
|
| Long-Term Debt | 108.27 | 106.14 | 75.81 | - | - | Upgrade
|
| Long-Term Leases | 3.94 | 0.49 | 1.26 | 1.95 | 2.55 | Upgrade
|
| Other Long-Term Liabilities | - | 1.15 | 1.34 | - | - | Upgrade
|
| Total Liabilities | 227.72 | 162.99 | 118.22 | 45.37 | 20.55 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.05 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 1,177 | 1,064 | 974.36 | 813.04 | 625.76 | Upgrade
|
| Retained Earnings | -1,155 | -894.74 | -710.06 | -528.94 | -459.33 | Upgrade
|
| Comprehensive Income & Other | -0.04 | 0.13 | -0.09 | -0 | 0.05 | Upgrade
|
| Total Common Equity | 21.73 | 169.76 | 264.26 | 284.15 | 166.53 | Upgrade
|
| Shareholders' Equity | 164.55 | 169.76 | 264.26 | 284.15 | 166.53 | Upgrade
|
| Total Liabilities & Equity | 392.27 | 332.75 | 382.48 | 329.52 | 187.07 | Upgrade
|
| Total Debt | 113.75 | 107.4 | 77.75 | 2.55 | 3.09 | Upgrade
|
| Net Cash (Debt) | 206.82 | 168.44 | 255.53 | 292.3 | 169.71 | Upgrade
|
| Net Cash Growth | 22.78% | -34.08% | -12.58% | 72.24% | -41.26% | Upgrade
|
| Net Cash Per Share | 3.39 | 2.92 | 4.90 | 5.89 | 3.85 | Upgrade
|
| Filing Date Shares Outstanding | 63.22 | 60.14 | 56.75 | 50.33 | 50.18 | Upgrade
|
| Total Common Shares Outstanding | 62.39 | 59.43 | 56.61 | 50.28 | 44.24 | Upgrade
|
| Working Capital | 258.68 | 253.07 | 314.43 | 264.96 | 163.67 | Upgrade
|
| Book Value Per Share | 0.35 | 2.86 | 4.67 | 5.65 | 3.76 | Upgrade
|
| Tangible Book Value | 15.56 | 162.73 | 256.38 | 279.49 | 166.53 | Upgrade
|
| Tangible Book Value Per Share | 0.25 | 2.74 | 4.53 | 5.56 | 3.76 | Upgrade
|
| Machinery | 2.69 | 2.7 | 2.65 | 2.37 | 1.93 | Upgrade
|
| Leasehold Improvements | 2.71 | 2.71 | 2.71 | 2.71 | 2.71 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.